gabapentin has been researched along with 2019 Novel Coronavirus Disease in 8 studies
Gabapentin: A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME.
gabapentin : A gamma-amino acid that is cyclohexane substituted at position 1 by aminomethyl and carboxymethyl groups. Used for treatment of neuropathic pain and restless legs syndrome.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The goal of this study was to evaluate the effectiveness of gabapentin (GBT) alone and in combination with montelukast (MTL) for improving cough." | 9.51 | The effectiveness of gabapentin and gabapentin/montelukast combination compared with dextromethorphan in the improvement of COVID-19- related cough: A randomized, controlled clinical trial. ( Dolatshahi, K; Hakamifard, A; Khorvash, F; Nasirharandi, S; Nasirian, M; Soltani, R, 2022) |
| "The goal of this study was to evaluate the effectiveness of gabapentin (GBT) alone and in combination with montelukast (MTL) for improving cough." | 5.51 | The effectiveness of gabapentin and gabapentin/montelukast combination compared with dextromethorphan in the improvement of COVID-19- related cough: A randomized, controlled clinical trial. ( Dolatshahi, K; Hakamifard, A; Khorvash, F; Nasirharandi, S; Nasirian, M; Soltani, R, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 8 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Soltani, R | 2 |
| Nasirharandi, S | 1 |
| Khorvash, F | 1 |
| Nasirian, M | 1 |
| Dolatshahi, K | 1 |
| Hakamifard, A | 2 |
| Ito, S | 3 |
| Shimamura, Y | 3 |
| Matsumoto, H | 3 |
| Garcia, JAP | 2 |
| Miller, E | 2 |
| Norwood, TG | 2 |
| Dorin, NA | 2 |
| Grayson, J | 2 |
| Woodworth, B | 2 |
| Cho, DY | 2 |
| Aksan, F | 1 |
| Nelson, EA | 1 |
| Swedish, KA | 1 |
| Korem, S | 1 |
| Gandhi, H | 1 |
| Dayag, DB | 1 |
| Kopacz, A | 1 |
| Ludwig, C | 1 |
| Tarbox, M | 1 |
| Queler, SC | 1 |
| Towbin, AJ | 1 |
| Milani, C | 1 |
| Whang, J | 1 |
| Sneag, DB | 1 |
3 trials available for gabapentin and 2019 Novel Coronavirus Disease
5 other studies available for gabapentin and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Gabapentin improves parosmia after COVID-19 infection.
Topics: COVID-19; Gabapentin; Humans; Olfaction Disorders; Smell | 2023 |
Gabapentin improves parosmia after COVID-19 infection.
Topics: COVID-19; Gabapentin; Humans; Olfaction Disorders; Smell | 2023 |
Gabapentin improves parosmia after COVID-19 infection.
Topics: COVID-19; Gabapentin; Humans; Olfaction Disorders; Smell | 2023 |
Gabapentin improves parosmia after COVID-19 infection.
Topics: COVID-19; Gabapentin; Humans; Olfaction Disorders; Smell | 2023 |
A COVID-19 patient with intense burning pain.
Topics: Acetaminophen; Analgesics; Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome; Back Pain; | 2020 |
Guillain-Barré syndrome associated with COVID-19 disease.
Topics: Analgesics; Betacoronavirus; Brain; Coronavirus Infections; COVID-19; Diagnosis, Differential; Femal | 2020 |
Atypical cutaneous and musculoskeletal manifestation of SARS-CoV-2: 'COVID-19 toes' and spasticity in a 48-year-old woman.
Topics: Analgesics; Blister; COVID-19; Female; Foot Diseases; Gabapentin; Humans; Middle Aged; Muscle Spasti | 2021 |
Parsonage-Turner Syndrome Following COVID-19 Vaccination: MR Neurography.
Topics: Adult; Analgesics; Brachial Plexus; Brachial Plexus Neuritis; COVID-19; COVID-19 Vaccines; Gabapenti | 2022 |